Patent Assignment
Reel/Frame 022602/0542
Assignment of Assignor's Interest
Recorded: 2009-04-28
Pages: 5
Assignor
BIOGEN IDEC INC.
Executed: 2009-04-09
Assignee
BIOGEN IDEC MA INC.
14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(11)
Treatment of cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
Application:
09/772,938 →
Publication:
US 2002/0006404
Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy
Application:
09/834,933 →
Publication:
US 2001/0018041
Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
Application:
09/855,717 →
Publication:
US 2002/0028178
Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy
Application:
10/096,963 →
Publication:
US 2003/0180292
Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
Application:
10/952,442 →
Publication:
US 2005/0123540
Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
Application:
11/464,130 →
Publication:
US 2006/0286100
Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
Application:
11/464,135 →
Publication:
US 2006/0286101
Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
Application:
11/840,573 →
Publication:
US 2008/0213167
Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
Application:
11/840,576 →
Publication:
US 2008/0213260
Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
Application:
11/840,580 →
Publication:
US 2008/0213168
Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
Application:
11/840,584 →
Publication:
US 2008/0171056
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 13, 2001
From: HANNA, NABIL; HARIHARAN, KANDASAMY
To: IDEC PHARMACEUTICALS CORPORATION
Reel/Frame 012158/0081 →
Assignment of Assignor's Interest
Jun 12, 2003
From: HANNA, NABIL; HARIHARAN, KANDASAMY
To: IDEC PHARMACEUTICALS CORPORATION
Reel/Frame 014176/0400 →
Change of Name
Aug 6, 2004
From: IDEC PHARMACEUTICALS CORPORATION
To: BIOGEN IDEC INC.
Reel/Frame 015044/0873 →
Assignment of Assignor's Interest
May 28, 2009
From: HANNA, NABIL; HARIHARAN, KANDASAMY
To: IDEC PHARMACEUTICALS CORPORATION
Reel/Frame 022747/0775 →